Igor Efimov, PhD, Chairman, Scientific Advisory Board (see board of directors page for bio).
Professor Michel Haissaguerre is the head of the Department of Cardiology, Electrophysiology and Pacing at Centre Hospitalier Universitaire, in Bordeaux, France. In 2012, he earned the lifetime achievement award for his contributions to the field of AF ablation at Heart Rhythm Society. He is a world-wide prominent Electrophysiologist contributing many key discoveries, particularly in the field of atrial fibrillation.
R. Hardwin Mead, MD practices cardiac electrophysiology and cardiology, primarily at Sequoia Hospital in Redwood City, CA. Dr. Mead has been instrumental in the development of numerous cardiovascular technologies and has worked with numerous start-up companies in the past. He has served on various physician advisory boards including Medtronic for the past 20 years and the initial scientific advisory board for Ventritex, now part of St. Jude Medical.
Nicholas Peters, MD is a Professor of Cardiology and the Head of Cardiac Electrophysiology at Imperial College in London. He is on the Board of Trustees, The Founding Research Committee, and Board Liaison for Research of Heart Rhythm Society. He is also director of the ElectroCardioMaths Programme. He has more than 100 peer-reviewed papers and holds patents in the field.
Patrick Tchou, MD is a distinguished senior cardiac electrophysiologist at Cleveland Clinic, Cleveland, OH. Dr. Tchou is a world-recognized key opinion leader in cardiac arrhythmias, including atrial and ventricular fibrillation.
Mark Richards, MD, PhD is a Cardiac Electrophysiologist at Northwest Ohio Cardiology Consultants in Toledo, OH. He is a medical and technical advisor to Cardialen and a specialist consultant to the cardiac device industry.
Richard Schuessler, PhD is a Research Professor of Surgery & Biomedical Engineering at Washington University School of Medicine in St. Louis, MO. Dr. Schuessler is a leading researcher in the field of atrial fibrillation.
Rahul Mehra, PhD, is a cardiac scientist and scientific consultant who received his bachelor’s degree in Electrical Engineering from Indian Institute of Technology (IIT) in India and his PhD in Bio-Medical Engineering from the Polytechnic Institute of New York in 1975. He was a research scientist at Montefiore Hospital in New York City, Director of Computerized Electrophysiology at the Brooklyn VA Medical Center and Assistant Professor of Medicine at the Downstate Medical Center till 1983. He joined Medtronic, Inc. in 1983 and held various research positions in the Cardiac Rhythm Disease Management group, leading research programs responsible for the development of implantable defibrillators used in the management of sudden cardiac death. He also led research programs to develop devices for treatment and monitoring of atrial fibrillation. Dr. Mehra holds over 60 patents on technologies for management of cardiac rhythm disturbances and has authored over 90 manuscripts and 24 book chapters. Prior to retiring from Medtronic in 2009, he was responsible for Market Development in Emerging Countries. Rahul was awarded a Fellowship of the American Institute of Medical and Biological Engineering in 2006. He is a Bakken Fellow as well as a Medtronic Senior Technical Fellow. In 2011 he received the Professional Career Achievement Award from the IEEE Engineering in Medicine and Biology Society.
Les Bookoff, JD is a partner at Bookoff McAndrews, an intellectual property law firm where his practice has a particular emphasis on medical device technologies. He analyzes patent portfolios of competitors to counsel clients regarding acquisition of technology, licensing, contemplated products, and potential design-around options. He has represented clients in dozens of due diligence investigations during investment transactions, mergers, and acquisitions. His technical experience extends to diverse technologies in the mechanical and electro-mechanical fields.
Dinesh Melwani, JD is also a partner at Bookoff McAndrews. There he works closely with clients to develop patent strategies that protect their innovative technologies and thereby maximize the potential for commercial success. Dinesh is often called upon for his ability to translate IP risks into business risks, and provide strategic guidance and oversight.
Brad Pedersen, JD is a partner at Patterson Thuente Christensen Pedersen, where he concentrates his practice in the areas of high-technology, computer, software and medical device patent prosecution strategy, licensing and litigation. Brad provides clients with practical and pragmatic advice on the development, management and enforcement of IP portfolios, based on his wide range of experiences. As an inventor, entrepreneur and former in-house counsel, he has a real-world foundation from which to create effective IP portfolios and strategies.
Bob Thompson, MPA/MS, is President of Comprehensive Reimbursement Solutions, consultancy dedicated to device reimbursement solutions. Bob was highly involved in the reimbursement project for the Medtronic Jewel AF Atrial Defibrillator device.
Andrew Hoyne, LLM/JD is practicing at Polsinelli Shughart (St. Louis, MO), one of the top 100 law firms in the US. Mr. Hoyne’s life science clients have included multi-billion dollar corporations, Big Ten universities, and emerging companies in fields including pharmaceuticals, medical devices, research services, agriculture, and bio-energy. Over the past dozen years, he has represented his clients in raising over $100 million of financing from venture capital funds, angels, development organizations and other funding sources. He has also represented his clients in partnering agreements with Monsanto, Zimmer, Sangamo and other companies. Client exits have included sales to Monsanto, Viasys (now part of Carefusion) and Avant Pharmaceuticals.